TY - JOUR
T1 - Directly administered antiretroviral therapy in an urban methadone maintenance clinic
T2 - A nonrandomized comparative study
AU - Lucas, Gregory M.
AU - Weidle, Paul J.
AU - Hader, Shannon
AU - Moore, Richard D.
PY - 2004/6/1
Y1 - 2004/6/1
N2 - Methadone-maintenance treatment clinics are strategically appealing sites for provision of directly administered antiretroviral therapy (DAART) to human immunodeficiency virus type 1 (HIV-1)-infected injection drug users (IDUs). We initiated an ongoing DAART protocol at a university-associated methadone clinic in April 2001, which continues to enroll participants. Participants ingested antiretroviral medications under direct supervision on days they attended the clinic; evening doses and doses on "methadone take-home days" were self-administered. Comparison IDUs receiving either standard care or treatment-adherence support were randomly selected from the population of the HIV-1 clinic where DAART participants received their primary care for HIV-1 infection, with frequency matching by sex, prior antiretroviral exposure, and receipt of methadone therapy. In an intention-to-treat analysis, 79% of DAART participants achieved HIV-1 RNA levels of <400 copies/mL by month 6 of therapy, compared with 54% in the standard care group (P = .035) and 48% in the adherence support group (P = .008). The preliminary results of this study both suggest that DAART can be feasible and acceptable to patients in a methadone clinic setting and provide impetus for further study of this treatment strategy in randomized controlled trials.
AB - Methadone-maintenance treatment clinics are strategically appealing sites for provision of directly administered antiretroviral therapy (DAART) to human immunodeficiency virus type 1 (HIV-1)-infected injection drug users (IDUs). We initiated an ongoing DAART protocol at a university-associated methadone clinic in April 2001, which continues to enroll participants. Participants ingested antiretroviral medications under direct supervision on days they attended the clinic; evening doses and doses on "methadone take-home days" were self-administered. Comparison IDUs receiving either standard care or treatment-adherence support were randomly selected from the population of the HIV-1 clinic where DAART participants received their primary care for HIV-1 infection, with frequency matching by sex, prior antiretroviral exposure, and receipt of methadone therapy. In an intention-to-treat analysis, 79% of DAART participants achieved HIV-1 RNA levels of <400 copies/mL by month 6 of therapy, compared with 54% in the standard care group (P = .035) and 48% in the adherence support group (P = .008). The preliminary results of this study both suggest that DAART can be feasible and acceptable to patients in a methadone clinic setting and provide impetus for further study of this treatment strategy in randomized controlled trials.
UR - http://www.scopus.com/inward/record.url?scp=2942622131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2942622131&partnerID=8YFLogxK
U2 - 10.1086/421405
DO - 10.1086/421405
M3 - Article
C2 - 15156431
AN - SCOPUS:2942622131
SN - 1058-4838
VL - 38
SP - S409-S413
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - SUPPL. 5
ER -